{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:57:47Z","timestamp":1761929867531,"version":"3.37.3"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SR\/SO\/HS-107\/2007"],"award-info":[{"award-number":["SR\/SO\/HS-107\/2007"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.exppara.2017.02.019","type":"journal-article","created":{"date-parts":[[2017,3,3]],"date-time":"2017-03-03T03:34:12Z","timestamp":1488512052000},"page":"30-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in India"],"prefix":"10.1016","volume":"176","author":[{"given":"Neeloo","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2017.02.019_bib1","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/932549","article-title":"Enolase: a key player in the metabolism and a probable virulence factor of trypanosomatid parasites\u2014perspectives for its use as a therapeutic target","volume":"2011","author":"Avil\u00e1n","year":"2011","journal-title":"Enzyme Res."},{"issue":"2","key":"10.1016\/j.exppara.2017.02.019_bib2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molbiopara.2011.06.004","article-title":"Differential expression of proteins in antimony-susceptible and-resistant isolates of Leishmania donovani","volume":"179","author":"Biyani","year":"2011","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.exppara.2017.02.019_bib3","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpddr.2014.05.002","article-title":"Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum","volume":"4","author":"Brotherton","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"issue":"11","key":"10.1016\/j.exppara.2017.02.019_bib4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.exppara.2017.02.019_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jprot.2009.08.006","article-title":"Proteomic characterization of the released\/secreted proteins of Leishmania (Viannia) braziliensis promastigotes","volume":"73","author":"Cuervo","year":"2009","journal-title":"J.\u00a0proteomics"},{"issue":"2","key":"10.1016\/j.exppara.2017.02.019_bib6","doi-asserted-by":"crossref","first-page":"e1514","DOI":"10.1371\/journal.pntd.0001514","article-title":"Molecular mechanisms of drug resistance in natural Leishmania populations vary with genetic background","volume":"6","author":"Decuypere","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"6","key":"10.1016\/j.exppara.2017.02.019_bib7","doi-asserted-by":"crossref","first-page":"e20786","DOI":"10.1371\/journal.pone.0020786","article-title":"Intracellular targeting specificity of novel phthalocyanines assessed in a host-parasite model for developing potential photodynamic medicine","volume":"6","author":"Dutta","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.exppara.2017.02.019_bib8","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1371\/journal.pone.0000040","article-title":"Mapping the antigenicity of the parasites in Leishmania donovani infection by proteome serology","volume":"1","author":"Forgber","year":"2006","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.exppara.2017.02.019_bib9","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1471-4922(02)02352-8","article-title":"Interaction of Leishmania with the host macrophage","volume":"18","author":"Handman","year":"2002","journal-title":"Trends Parasitol."},{"issue":"7","key":"10.1016\/j.exppara.2017.02.019_bib10","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.biopha.2013.04.005","article-title":"The role of aldehyde dehydrogenase (ALDH) in cancer drug resistance","volume":"67","author":"Januchowski","year":"2013","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.exppara.2017.02.019_bib11","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.exppara.2010.02.011","article-title":"Leishmania donovani: oral therapy with glycosyl 1,4-dihydropyridine analogue showing apoptosis like phenotypes targeting pteridine reductase 1 in intracellular amastigotes","volume":"125","author":"Kaur","year":"2010","journal-title":"Exp. Parasitol."},{"issue":"5","key":"10.1016\/j.exppara.2017.02.019_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/jac\/dks507","article-title":"A\u00a0member of RAS oncogene family, RAP1A signaling, mediates antileishmanial activity of monastrol","volume":"68","author":"Kaur","year":"2013","journal-title":"J.\u00a0Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.exppara.2017.02.019_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.parint.2006.10.005","article-title":"Possibility of membrane modification as a mechanism of antimony resistance in Leishmania donovani","volume":"56","author":"Kothari","year":"2007","journal-title":"Parasitol. Int."},{"issue":"2","key":"10.1016\/j.exppara.2017.02.019_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.exppara.2006.12.008","article-title":"Degradation of pteridine reductase 1 (PTR1) enzyme during growth phase in the protozoan parasite Leishmania donovani","volume":"116","author":"Kumar","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"4","key":"10.1016\/j.exppara.2017.02.019_bib15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2125.2010.03716.x","article-title":"Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani","volume":"70","author":"Kumar","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.exppara.2017.02.019_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4269\/ajtmh.2007.77.89","article-title":"Treatment of kala-azar in southern Sudan using a 17-day regimen of sodium stibogluconate combined with paromomycin: a retrospective comparison with 30-day sodium stibogluconate monotherapy","volume":"77","author":"Melaku","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2017.02.019_bib17","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.euprot.2014.07.003","article-title":"Proteomic analysis of metacyclogenesis in Leishmania infantum wild-type and PTR1 null mutant","volume":"4","author":"Moreira","year":"2014","journal-title":"EuPA Open Proteomics"},{"issue":"2","key":"10.1016\/j.exppara.2017.02.019_bib18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1242\/jcs.94.2.333","article-title":"Enolase exists in the fluid phase of cytoplasm in 3T3 cells","volume":"94","author":"Pagliaro","year":"1989","journal-title":"J.\u00a0cell Sci."},{"issue":"6","key":"10.1016\/j.exppara.2017.02.019_bib19","first-page":"282","article-title":"Stage-specific regulation of gene expression in Leishmania","volume":"69","author":"Papadopoulou","year":"2003","journal-title":"ASM News-American Soc. Microbiol."},{"issue":"3","key":"10.1016\/j.exppara.2017.02.019_bib20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.7705\/biomedica.v32i3.392","article-title":"Differential expression of proteins in Leishmania (Viannia) panamensis associated with mechanisms of resistance to meglumine antimoniate","volume":"32","author":"Pel\u00e1ez","year":"2012","journal-title":"Biom\u00e9dica"},{"issue":"3","key":"10.1016\/j.exppara.2017.02.019_bib21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.exppara.2007.01.008","article-title":"Leishmania mexicana: molecular cloning and characterization of enolase","volume":"116","author":"Qui\u00f1ones","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"6","key":"10.1016\/j.exppara.2017.02.019_bib22","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1128\/AAC.39.6.1234","article-title":"In\u00a0vitro antileishmanial properties of tri-and pentavalent antimonial preparations","volume":"39","author":"Roberts","year":"1995","journal-title":"Antimicrob. agents Chemother."},{"issue":"4","key":"10.1016\/j.exppara.2017.02.019_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.exppara.2009.08.003","article-title":"Proteomic analysis of wild type and arsenite-resistant Leishmania donovani","volume":"123","author":"Sharma","year":"2009","journal-title":"Exp. Parasitol."},{"issue":"3","key":"10.1016\/j.exppara.2017.02.019_bib24","first-page":"411","article-title":"Drug resistance mechanisms in clinical isolates of Leishmania donovani","volume":"123","author":"Singh","year":"2006","journal-title":"Indian J. Med. Res."},{"issue":"06","key":"10.1016\/j.exppara.2017.02.019_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1017\/S0031182007002284","article-title":"Sundar, Differential gene expression analysis in antimony-unresponsive Indian kala azar (visceral leishmaniasis) clinical isolates by DNA microarray","volume":"134","author":"Singh","year":"2007","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.exppara.2017.02.019_bib26","first-page":"345","article-title":"Visceral leishmaniasis-current therapeutic modalities","volume":"123","author":"Sundar","year":"2006","journal-title":"Indian J. Med. Res."},{"issue":"1","key":"10.1016\/j.exppara.2017.02.019_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1074\/mcp.M600319-MCP200","article-title":"A\u00a0proteomics screen implicates HSP83 and a small kinetoplastid calpain-related protein in drug resistance in Leishmania donovani clinical field isolates by modulating drug-induced programmed cell death","volume":"6","author":"Vergnes","year":"2007","journal-title":"Mol. Cell. Proteomics"},{"issue":"5","key":"10.1016\/j.exppara.2017.02.019_bib28","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/pmic.200500417","article-title":"Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia\u2013an in\u00a0vivo study","volume":"6","author":"Verrills","year":"2006","journal-title":"Proteomics"},{"issue":"2","key":"10.1016\/j.exppara.2017.02.019_bib29","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.molbiopara.2012.03.002","article-title":"Discovery of factors linked to antimony resistance in Leishmania panamensis through differential proteome analysis","volume":"183","author":"Walker","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.exppara.2017.02.019_bib30","unstructured":"WHO Fact sheet No 375, January 2014."},{"issue":"2","key":"10.1016\/j.exppara.2017.02.019_bib31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbiopara.2010.05.015","article-title":"Elevated levels of tryparedoxin peroxidase in antimony unresponsive Leishmania donovani field isolates","volume":"173","author":"Wyllie","year":"2010","journal-title":"Mol. Biochem. Parasitol."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941630217X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448941630217X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T02:57:46Z","timestamp":1655953066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448941630217X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":31,"alternative-id":["S001448941630217X"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2017.02.019","relation":{},"ISSN":["0014-4894"],"issn-type":[{"type":"print","value":"0014-4894"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating genomics and proteomics permits identification of immunodominant antigens associated with drug resistance in human visceral leishmaniasis in India","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2017.02.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}